Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer
JTO Clin Res Rep
.
2020 Feb 12;1(1):100002.
doi: 10.1016/j.jtocrr.2020.100002.
eCollection 2020 Mar.
Authors
Waleed Kian
1
,
Dina Levitas
1
,
Wafeek Alguayn
1
,
Walid Shalata
1
,
Adam A Sharb
2
,
Daniel Levin
2
,
Laila C Roisman
1
,
Margarita Tokar
1
,
Nir Peled
1
,
Alexander Yakobson
1
Affiliations
1
The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.
2
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
PMID:
34589909
PMCID:
PMC8474458
DOI:
10.1016/j.jtocrr.2020.100002
No abstract available
Publication types
Case Reports